These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2647915)

  • 1. Bone marrow autotransplantation for solid tumors--prospects.
    Frei E; Antman K; Teicher B; Eder P; Schnipper L
    J Clin Oncol; 1989 Apr; 7(4):515-26. PubMed ID: 2647915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A perspective on dose-intensive therapy with autologous bone marrow transplantation for solid tumors.
    Ayash LJ; Antman K; Cheson BD
    Oncology (Williston Park); 1991 Mar; 5(3):25-33; discussion 33, 36, 41. PubMed ID: 1829944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients.
    Eder JP; Elias A; Shea TC; Schryber SM; Teicher BA; Hunt M; Burke J; Siegel R; Schnipper LE; Frei E
    J Clin Oncol; 1990 Jul; 8(7):1239-45. PubMed ID: 2162912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous bone marrow transplantation for metastatic breast cancer.
    Saez RA; Selby GB; Slease RB; Epstein RB; Mandanas RA; Confer DL
    J Okla State Med Assoc; 1994 Sep; 87(9):405-10. PubMed ID: 7996314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer.
    Eder JP; Antman K; Peters W; Henner WD; Elias A; Shea T; Schryber S; Andersen J; Come S; Schnipper L
    J Clin Oncol; 1986 Nov; 4(11):1592-7. PubMed ID: 3534155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study.
    Ayash LJ; Elias A; Wheeler C; Reich E; Schwartz G; Mazanet R; Tepler I; Warren D; Lynch C; Gonin R
    J Clin Oncol; 1994 Jan; 12(1):37-44. PubMed ID: 7505807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer.
    Peters WP; Shpall EJ; Jones RB; Olsen GA; Bast RC; Gockerman JP; Moore JO
    J Clin Oncol; 1988 Sep; 6(9):1368-76. PubMed ID: 3047332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curative cancer chemotherapy.
    Frei E
    Cancer Res; 1985 Dec; 45(12 Pt 1):6523-37. PubMed ID: 2998603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose intensification using combination alkylating agents and autologous bone marrow support in the treatment of primary and metastatic breast cancer: a review of the Duke Bone Marrow Transplantation Program experience.
    Peters WP
    Prog Clin Biol Res; 1990; 354B():185-94. PubMed ID: 2236164
    [No Abstract]   [Full Text] [Related]  

  • 10. Consolidation with high-dose combination alkylating agents with bone marrow transplantation significantly improves disease-free survival in hormone-insensitive metastatic breast cancer in complete remission compared with intensive standard-dose chemotherapy alone.
    Vredenburgh JJ; Coniglio D; Broadwater G; Jones RB; Ross M; Shpall EJ; Hussein A; Rizzieri D; Marks LB; Gilbert C; Affronti ML; Moore S; McDonald C; Petros WP; Peters WP
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):195-203. PubMed ID: 16443517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose chemotherapy with autologous stem cell support for breast cancer: a review of the Dana-Farber Cancer Institute/Beth Israel Hospital experience.
    Ayash LJ; Elias A; Wheeler C; Tepler I; Schwartz G; Schnipper L; Frei E; Antman K
    J Hematother; 1993; 2(4):507-11. PubMed ID: 7916250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of high-dose chemotherapy with autologous bone marrow transplantation in the treatment of breast cancer.
    Hortobagyi GN
    Bone Marrow Transplant; 1988 Nov; 3(6):525-30. PubMed ID: 3063320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer.
    Ayash LJ; Wheeler C; Fairclough D; Schwartz G; Reich E; Warren D; Schnipper L; Antman K; Frei E; Elias A
    J Clin Oncol; 1995 Aug; 13(8):2043-9. PubMed ID: 7636547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of autologous bone marrow transplantation in the treatment of solid tumors.
    Herzig RH
    Semin Oncol; 1992 Jun; 19(3 Suppl 7):7-12. PubMed ID: 1615332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of multiple myeloma.
    San Miguel JF; Bladé Creixenti J; García-Sanz R
    Haematologica; 1999 Jan; 84(1):36-58. PubMed ID: 10091392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of metastatic breast cancer with a split-course high-dose chemotherapy regimen and autologous bone marrow transplantation.
    Ghalie R; Richman CM; Adler SS; Cobleigh MA; Korenblit AD; Manson SD; McLeod BC; Taylor SG; Valentino LA; Wolter J
    J Clin Oncol; 1994 Feb; 12(2):342-6. PubMed ID: 8113841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docetaxel in combination chemotherapy for metastatic breast cancer.
    Khayat D; Antoine E
    Semin Oncol; 1997 Aug; 24(4 Suppl 13):S13-19-S13-26. PubMed ID: 9335513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous bone marrow transplantation in the treatment of breast cancer: clinical and technologic strategies.
    Vaughan WP
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):55-8. PubMed ID: 8211216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose combination alkylating agents with autologous bone marrow support: a Phase 1 trial.
    Peters WP; Eder JP; Henner WD; Schryber S; Wilmore D; Finberg R; Schoenfeld D; Bast R; Gargone B; Antman K
    J Clin Oncol; 1986 May; 4(5):646-54. PubMed ID: 3517240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High-dose chemotherapy as a strategy to overcome drug resistance in solid tumors].
    Selle F; Gligorov J; Soares DG; Lotz JP
    Bull Cancer; 2016 Oct; 103(10):861-868. PubMed ID: 27641463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.